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Strain variations among Streptococcus pyogenes T1- 
a possible explanation for bacteremia epidemics? 
Anders Osterlund and Lars Engstrand 
Department of Clinical Microbiology, University Hospital, Uppsala, Sweden 
Objective: To study the genetic diversity among consecutive blood culture isolates of Streptococcus pyogenes TI, in 
order to examine the possibility of different bacterial clones being responsible for two epidemics during the period 
Methods: DNA-fingerprinting patterns were obtained by use of the following methods: macrorestriction of genomic 
DNA followed by pulsed-field gel electrophoresis (PFGE), random amplified polymorphic DNA (RAPD) analysis, and 
restriction fragment length polymorphism of the vir regulon (Vir-typing). Possession of the speA gene was investigated 
by use of a polymerase chain reaction (PCR) method, and further characterization of the gene was done by sequencing 
of the PCR products from six strains. 
Results: All isolates contained the speA gene. Sequencing data from six isolates revealed the presence of the speA.2 
allele. Using RAPD analysis, it was possible to distinguish between DNA-fingerprinting patterns of the S. pyogenes T I  
strains from the two epidemics. 
Conclusions: The present study reveals different DNA-fingerprinting patterns from blood culture isolates of S. 
pyogenes T I  from two local epidemics, 1988-89 and 1994-95. Since the differences seen do not necessarily reflect 
different antigenic properties or changed virulence among the isolates, further studies addressing this question should 
be performed. 
Key words: Streptococcus pyogenes, DNA fingerprinting, epidemic, invasive, speA gene 
1986-95. 
INTRODUCTION 
One of the questions that has been raised after 
numerous reports of severe Streptococcus pyogenes 
disease epidemics since the mid-1980s is whether the 
epidemics have been caused by ‘new’ virulent strains or 
have been the result of insufficient immunity in the 
affected populations. 
Most researchers have observed an association 
between invasive disease and the S. pyogener serotypes 
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M1 and M3 [l-61. It has been suggested that virulence 
is associated with specific strains and not broadly related 
to certain serotypes [7] .  It  has further been proposed 
that the epidemics can be attributed to the spread of 
a few highly virulent clones [%lo]. However, clonal 
diversity among isolates causing invasive disease, favor- 
ing the hypothesis that host immunity is of major 
importance in the pathogenesis, has been found by 
others [I 1-13]. 
In Sweden, a nationwide epidemic of bacteremia 
with a 33% case-fatality rate caused by S. pyogenes 
serotype Tl /MI occurred in 1988-89 [3,14]. In this 
epidemic the highest age-specific incidence occurred 
in the age group >70 years. This was also observed in 
the county of Uppsala. In the 1994-95 epidemic, 
however, middle-aged people were the most affected in 
the county of Uppsala [14]. This favors the hypothesis 
that the same bacterial clone could have caused both 
epidemics, and that different subpopulations were 
affected during these two epidemics. 
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In order to examine the possibility of a novel 
bacterial clone as the cause of the 1994-95 epidemic 
in Uppsala county, Sweden, we have compared all 
S. pyogenes T1 blood culture isolates from 1986 to 1995 
with respect to their DNA-fingerprinting patterns and 
possession of the gene encoding for the erythrogenic 
toxin, speA. Further characterization of the speA gene, 
from three strains fi-om each of the two epidemics, was 
carried out by sequencing a 300-base-pair region of the 
gene. Methods used for DNA fingerprinting were 
macrorestriction of genomic DNA followed by pulsed- 
field gel electrophoresis (PFGE), random amplified 
polymorphic DNA (RAPD) analysis, and restriction 
fragment length polymorphism of the oir regulon (Vir- 
typing). 
MATERIALS AND METHODS 
Bacterial strains 
The 24 consecutive clinical isolates of S. pyogenes T1 
fiom bacteremia cases were obtained during the years 
1986-95 from the Department of Clinical Micro- 
biology, Uppsala University Hospital, Sweden. T- 
typing was performed using antisera from Chemapol 
(Prague, Czech Republic). The isolates are listed in 
Table 1. 
Table 1 Isolates of S. pyopenes T1 used in the studv 
~ ~ ~~ 
PFGE RAPD 
Date of isolate lane no. lane no. 
860422 
No cases found in 1987 
880329 
880415' 
890129 
890228" 
890307 
890426" 
890508 
890516 
890709 
891102 
900128 
900224 
900418 
No cases found in 1991 
No cases found in 1992 
930615 
940105 
940423" 
940602" 
940609 
940825 
941 206 
95O13Oa 
950320 
950623 
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1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
Extraction of bacterial DNA 
Genomic DNA for macrorestriction followed by PFGE 
and Vir-typing was done using InCert agarose gel plugs 
(FMC Bioproducts, Rockland, Maine, USA) according 
to the method of  Miranda et al [l5]. For RAPD analysis 
and detection of the speA gene, the PCR reactions 
were performed on DNA using crude cell lysates. We 
used a method slightly moddied from that described by 
Hynes et al [16]. Briefly, a loopful of bacteria from an 
overnight culture on blood agar was digested in 50 pL 
of lysis buffer containing proteinase K, 0.2 m g / d ,  and 
1.0% Triton X-100 in TE buffer (10 mM Tris, 1 M 
EDTA, pH 8.0). The lysis was carried out for 45 min 
at 6OoC, followed by 10 min at 95°C for inactivation 
of proteinase K. 
Macrorestriction and PFGE 
Macrorestriction of genomic DNA was performed 
using the rare-cutting endonucleases SmuI and SfiI 
Poehringer Mannheim, Mannheim, Germany). These 
enzymes were chosen because they have been found to 
be the most suitable and discriminatory for S. pyogenes 
DNA [17]. Restriction digests were loaded into the 
wells of a 1.2% agarose gel, Sea-Plaque GTG (FMC 
Bioproducts), along with a molecular mass marker, 
Lambda Ladder PFG Marker (Biolabs, New England, 
Beverly, Massachusetts, USA). PFGE was carried out in 
'Isolate used for speA gene sequencing. 
a CHEF MAPPER (Bio-Rad, California, USA) for 
26.56 h at 6 V/cm. Ramping times were 1.79-73.58 s. 
The gels were then stained with ethidium bromide 
for 30 min and destained in distilled water for 17 h 
before being photographed under ultraviolet illumina- 
tion. 
RAPD analysis 
The PCR reaction was accomplished as previously 
described [18]. S i x  different primers, four of 10 bp and 
two of 20 bp, were tested separately or in combination. 
The best results were achieved when the 20-bp primer 
HSVPI (5'-CGACTTTGCCAGCCTGTACC) was 
used. 
Vir-typing 
Vir-typing was carried out as described by Gardiner 
et al, using PCR primers that correspond to conserved 
sequences flanking the emm-family genes [19]. Restric- 
tion cleavage was accomplished by use of Hue111 
(Boehringer Mannheim). The PCR products and 
Hue111 digests were electrophoresed in a 2% agarose 
gel, and visualized with ultraviolet illumination after 
ethidium bromide staining. 
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Figure 1 Comparison of PFGE patterns after SmaI cleavage from 24 consecutive blood culture isolates of S. pyogenes T1. Lane 
1 is from a strain isolated in 1986, lanes 2 and 3 from 1988, lanes 4-11 &om 1989, lanes 12-14 from 1990, lane 15 from 1993, 
lanes 16-21 from 1994, and lanes 22-24 from 1995 (see Table 1). h is the Lambda Ladder PFG Marker. 
M 1 2 3 4 5 6 7 8 9 1011 12131415 1 6 1 7 1 8 1 9 2 0 2 1  2223 
Figure 2 Comparison of RAPD analysis patterns from 23 consecutive blood culture isolates of S. pyogenes T1. Lanes 1 and 2 
are from strains isolated in 1988, lanes 3-10 from 1989, lanes 11-13 from 1990, lane 14 from 1993, lanes 15-20 from 1994, 
and lanes 21-23 6om 1995 (see Table 1). M is the 100 Base-Pair Ladder froni Pharmacia Biotech (Stockhoim, Sweden). 
Detection of the speA gene 
The method of Musser et al [8] was adopted for P C R  
amplification of the speA gene. Primers were SPA-1 
(5’-ATGGAAAACAATAAAAAAGTATTG) and SPA- 
2 (5'-TTACTTGGTTGTTAGGTAGACTTC) . The 
756-bp PCR products were electrophoresed in a 2% 
agarose gel, and visualized with ultraviolet illumination 
after ethidium bromide staining. The P C R  products 
from six strains, three from the 1988-89 epidemic 
and three from the 1994 epidemic, were studied by 
sequencing of the speA gene. Single-stranded DNA 
sequences from the P C R  products were obtained using 
the ABI PRISM dye terminator cycle sequencing ready 
reaction lat (Perkm-Elmer, Foster City, CA, USA) and 
an ABI PRISM 310 Genetic Analyzer (Perkin-Elmer). 
Three hundred base-pair fragments, including the 
variable region differentiating the alleles rpeA 1, speA2, 
and speA3, were compared with previously published 
sequencing data [20,21] using the computer software 
Sequencher version 3.0 (Gene Codes Corporation, 
Ann Arbor, MI, USA). 
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RESULTS 
Detection of the speA gene 
AU the 24 studied isolates contained the speA gene. Six 
strains, three from the 1988-89 epidemic and three 
fi-om the 1994-95 epidemic, were further examined by 
sequencing of a 300-bp fragment of the speA gene. 
Using the amino acid numbering system according to 
the method of Nelson et al [22], all six strains were 
shown to contain the speA2 allele, as their DNA 
sequences coded for valine at position 106 and serine 
at position 110. 
Vir-typing and macrorestriction followed by PFGE 
Vir-typing, as well as macrorestriction by the rare- 
cutting enzymes SmaI or SjiI followed by PFGE, 
revealed only minor differences in the patterns for 
occasional strains. Figure 1 shows the PFGE pattern 
after digestion of whole cell DNA fi-om the 24 strains 
with SrnaI. The only major difference seen among the 
patterns is the loss of an approximately 200-kb fi-ag- 
ment in lane 22. 
RAPD analysis 
Apart &om minor differences between the strains, 
RAPD analysis revealed two principal patterns (Figure 
2). One pattern was found in lanes 1-7 and 12-15. A 
second pattern was found in lanes 8, 9, 11 and 16-23. 
Thus, all isolates except two from the 1988-89 
epidemic showed the first pattern, and all but one of 
the isolates from the 1994-95 epidemic showed the 
second pattern. 
DISCUSSION 
In this study, we examined all blood culture isolates 
of S. pyogenes T1 from a time period covering two 
S. pyogenes bacteremia epidemics in Uppsala county, 
Sweden. 
The presence of the speA gene was studied because 
of its in vitro stability [23] and variable occurrence in 
strains causing invasive disease [12,13,24,25]. All 24 
isolates studied were found to contain the gene. Since 
the four naturally occurring alleles of the speA gene 
encode for toxins with differing superantigenic activity 
[26], we examined the speA gene from three strains 
from the 1988-89 epidemic and three from the 1994 
epidemic by DNA base sequencing. All strains were 
shown to contain the speAZ allele. This is in con- 
cordance with previous observations from Sweden, 
where S.  pyogenes strains containing the speA2 allele 
were isolated from patients with streptococcal toxic 
shock syndrome [27]. 
Thi: vir regulon of S. pyogenes consists of one or 
more of the following genes in linear order: the 
regulatory gene virR, and genes for IgG Fc receptor 
(frcA), ifor M-protein (emm), for M-protein-like IgA- 
binding proteins (enn) and for the C5a peptidase (scpA) 
[19,28,29]. Genetic variability within the emm gene 
family (,frrA, emm and enn) is prevalent, and constitutes 
the basis for Vir-typing [19,28-301. Vir-typing, as well 
as macrorestriction of genomic DNA by the rare- 
cutting enzymes SmaI or SjI followed by PFGE, 
are methods that have successfully been used for 
DNA fingerprinting of S. pyogenes strains [17,27, 
31,321. 'These methods were not sensitive enough to 
differentiate between strains of S. pyogenes T1 from 
the two epidemics. In a recent Scandinavian study of 
molecu1;tr comparisons of S. pyogenes T l M l  isolates, 
covering the same time interval as in this study, all the 
isolates studied were considered to be of a single clonal 
origin [33] .  It was concluded that the clonal nature 
of serotype M l T l  imposed restrictions on molecular 
typing. An alternative conclusion might have been that 
the methods used were not optimal. Using RAPD 
analysis, we were able to distinguish between the 
DNA-fingerprinting patterns of strains fi-om the two 
epidemics, 1988-89 and 1994-95. Whether these 
differences reflect different antigenic properties or altered 
virulence is, of course, not possible to determine from 
these data. However, antigenic differences among strains 
of the twl3 epidemics might explain how two epidemics 
caused by S. pyogenes T1 could occur in such a short 
timespan. 
Strains of S. pyogenes that are apparently identical 
to those isolated from invasive infections are usually 
found in high proportions among pharyngeal isolates in 
the population [5,14,34]. If the differences in DNA- 
fingerprinting patterns can be shown to reflect differ- 
ences in antigenic properties or virulence, DNA finger- 
printing of pharyngeal isolates, using RAPD analysis, 
might facilitate the prediction of new invasive S. 
pyogenes epidemics. 
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